Market Closed -
Bombay S.E.
11:00:50 06/05/2024 BST
|
5-day change
|
1st Jan Change
|
438.7
INR
|
-1.92%
|
|
+0.37%
|
+1.99%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
42,527
|
34,726
|
194,250
|
317,096
|
157,798
|
236,714
|
-
|
-
|
Enterprise Value (EV)
1 |
51,926
|
44,264
|
208,321
|
333,657
|
177,033
|
211,463
|
259,069
|
258,808
|
P/E ratio
|
45.4
x
|
13.6
x
|
19.8
x
|
38.4
x
|
20
x
|
132
x
|
57.1
x
|
34
x
|
Yield
|
0.38%
|
0.77%
|
0.55%
|
0.34%
|
0.68%
|
0.3%
|
0.33%
|
0.4%
|
Capitalization / Revenue
|
1.86
x
|
1.23
x
|
4.04
x
|
6.42
x
|
2.61
x
|
4.2
x
|
4.02
x
|
3.47
x
|
EV / Revenue
|
2.27
x
|
1.56
x
|
4.33
x
|
6.76
x
|
2.93
x
|
4.2
x
|
4.39
x
|
3.79
x
|
EV / EBITDA
|
14.6
x
|
7.84
x
|
13.4
x
|
23.5
x
|
11.1
x
|
27.2
x
|
22.7
x
|
16.6
x
|
EV / FCF
|
120
x
|
35.3
x
|
424
x
|
974
x
|
4,733
x
|
96
x
|
70.9
x
|
108
x
|
FCF Yield
|
0.84%
|
2.83%
|
0.24%
|
0.1%
|
0.02%
|
1.04%
|
1.41%
|
0.93%
|
Price to Book
|
2.73
x
|
1.96
x
|
15
x
|
9.49
x
|
3.91
x
|
5.62
x
|
5.21
x
|
4.57
x
|
Nbr of stocks (in thousands)
|
532,184
|
534,572
|
536,602
|
537,359
|
538,651
|
538,966
|
-
|
-
|
Reference price
2 |
79.91
|
64.96
|
362.0
|
590.1
|
293.0
|
439.2
|
439.2
|
439.2
|
Announcement Date
|
02/05/19
|
30/04/20
|
29/04/21
|
28/04/22
|
27/04/23
|
25/04/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
22,919
|
28,317
|
48,135
|
49,356
|
60,406
|
50,408
|
58,957
|
68,277
|
EBITDA
1 |
3,560
|
5,645
|
15,507
|
14,224
|
15,922
|
7,775
|
11,402
|
15,567
|
EBIT
1 |
1,918
|
3,773
|
13,456
|
11,709
|
12,681
|
3,929
|
7,211
|
11,007
|
Operating Margin
|
8.37%
|
13.32%
|
27.95%
|
23.72%
|
20.99%
|
7.79%
|
12.23%
|
16.12%
|
Earnings before Tax (EBT)
1 |
1,198
|
2,936
|
13,011
|
10,838
|
11,089
|
2,364
|
5,926
|
9,922
|
Net income
1 |
937.6
|
2,553
|
9,836
|
8,275
|
7,901
|
1,606
|
4,254
|
7,303
|
Net margin
|
4.09%
|
9.01%
|
20.43%
|
16.77%
|
13.08%
|
3.18%
|
7.22%
|
10.7%
|
EPS
2 |
1.760
|
4.786
|
18.28
|
15.35
|
14.64
|
2.970
|
7.696
|
12.93
|
Free Cash Flow
1 |
434
|
1,254
|
491.2
|
342.6
|
37.4
|
2,656
|
3,653
|
2,397
|
FCF margin
|
1.89%
|
4.43%
|
1.02%
|
0.69%
|
0.06%
|
5.25%
|
6.2%
|
3.51%
|
FCF Conversion (EBITDA)
|
12.19%
|
22.21%
|
3.17%
|
2.41%
|
0.23%
|
32.74%
|
32.03%
|
15.4%
|
FCF Conversion (Net income)
|
46.29%
|
49.12%
|
4.99%
|
4.14%
|
0.47%
|
136.31%
|
85.87%
|
32.82%
|
Dividend per Share
2 |
0.3000
|
0.5000
|
2.000
|
2.000
|
2.000
|
1.320
|
1.450
|
1.767
|
Announcement Date
|
02/05/19
|
30/04/20
|
29/04/21
|
28/04/22
|
27/04/23
|
25/04/24
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
12,884
|
14,119
|
12,785
|
12,035
|
10,288
|
14,248
|
15,389
|
15,759
|
15,448
|
13,809
|
11,818
|
13,633
|
13,597
|
14,331
|
13,502
|
EBITDA
1 |
4,263
|
4,722
|
3,954
|
3,479
|
2,853
|
3,967
|
4,542
|
4,489
|
4,036
|
2,855
|
1,667
|
2,650
|
2,648
|
2,690
|
-
|
EBIT
1 |
3,747
|
4,186
|
3,368
|
2,819
|
2,213
|
3,310
|
3,834
|
3,671
|
3,191
|
1,985
|
761.7
|
1,888
|
2,082
|
1,922
|
1,418
|
Operating Margin
|
29.08%
|
29.64%
|
26.34%
|
23.42%
|
21.51%
|
23.23%
|
24.91%
|
23.29%
|
20.66%
|
14.38%
|
6.45%
|
13.85%
|
15.31%
|
13.41%
|
10.5%
|
Earnings before Tax (EBT)
1 |
3,642
|
4,012
|
3,160
|
2,626
|
2,035
|
3,017
|
3,559
|
3,281
|
2,778
|
1,471
|
405.8
|
1,567
|
1,710
|
1,307
|
-
|
Net income
1 |
2,728
|
2,967
|
2,414
|
2,019
|
1,550
|
2,305
|
2,513
|
2,328
|
2,030
|
1,030
|
248.5
|
1,055
|
1,016
|
883.6
|
-
|
Net margin
|
21.18%
|
21.01%
|
18.88%
|
16.78%
|
15.06%
|
16.18%
|
16.33%
|
14.77%
|
13.14%
|
7.46%
|
2.1%
|
7.74%
|
7.47%
|
6.17%
|
-
|
EPS
2 |
5.070
|
5.500
|
4.480
|
3.740
|
2.850
|
4.280
|
4.660
|
4.320
|
3.760
|
1.900
|
0.4600
|
2.600
|
2.000
|
1.400
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
28/01/21
|
29/04/21
|
29/07/21
|
28/10/21
|
27/01/22
|
28/04/22
|
27/07/22
|
21/10/22
|
30/01/23
|
27/04/23
|
27/07/23
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
9,400
|
9,538
|
14,071
|
16,561
|
19,235
|
18,407
|
22,355
|
22,094
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.64
x
|
1.69
x
|
0.9074
x
|
1.164
x
|
1.208
x
|
2.269
x
|
1.961
x
|
1.419
x
|
Free Cash Flow
1 |
434
|
1,254
|
491
|
343
|
37.4
|
2,656
|
3,653
|
2,397
|
ROE (net income / shareholders' equity)
|
6.17%
|
15.3%
|
45%
|
27.8%
|
21.4%
|
5%
|
10.5%
|
14.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
13%
|
10.8%
|
2%
|
5%
|
8%
|
Assets
1 |
-
|
-
|
-
|
63,594
|
73,142
|
97,441
|
85,077
|
91,286
|
Book Value Per Share
2 |
29.30
|
33.10
|
24.20
|
62.20
|
75.00
|
78.20
|
84.30
|
96.20
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
2,538
|
2,220
|
6,839
|
8,768
|
9,902
|
9,160
|
7,067
|
6,696
|
Capex / Sales
|
11.07%
|
7.84%
|
14.21%
|
17.77%
|
16.39%
|
18.11%
|
11.99%
|
9.81%
|
Announcement Date
|
02/05/19
|
30/04/20
|
29/04/21
|
28/04/22
|
27/04/23
|
25/04/24
|
-
|
-
|
Last Close Price
439.2
INR Average target price
383.4
INR Spread / Average Target -12.70% Consensus |
1st Jan change
|
Capi.
|
---|
| +30.99% | 662B | | +21.96% | 546B | | -5.18% | 359B | | +17.06% | 323B | | +4.85% | 289B | | +13.68% | 234B | | +3.81% | 198B | | -10.63% | 194B | | +3.96% | 167B |
Other Pharmaceuticals
|